Search results for abx831421

Gedivumab, Abbexa, abx831421

Gedivumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Influenza A Virus Hemagglutinin HA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).